Cardiac Amyloidosis, An Infiltrative Heart Disease Presenting as Arrhythmia-A Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2017 Cardiac amyloidosis is a manifestation of amyloidosis which is a multisystem disorder. This is difficult to diagnose, rare disease which eventually leads to the mortality.
B Magesh +4 more
doaj +4 more sources
Role of Imaging in Evaluating Infiltrative Heart Disease. [PDF]
Curr Treat Options Cardiovasc Med, 2017 Infiltrative heart disease is caused by the deposition of abnormal substances in the heart and can lead to abnormalities in cardiac function and electrical conduction. Advances in non-invasive cardiovascular imaging have allowed for improved diagnosis of infiltrative heart disease, as well as ways to track disease progression or regression, thus ...
Divakaran S +6 more
europepmc +6 more sources
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. [PDF]
JACC Cardiovasc Imaging, 2012 The aim of this study was to perform direct quantification of myocardial extracellular volume fraction (ECF) with T1-weighted cardiac magnetic resonance (CMR) imaging in patients suspected to have infiltrative heart disease.Infiltrative heart disease refers to accumulation of abnormal substances within the myocardium.
Mongeon FP +5 more
europepmc +5 more sources
Classification of Infiltrative Heart Diseases MORAL-STAGE System
Clinical Medicine Insights: CardiologyInfiltrative heart disease (InHD) is a group of diseases characterized by the deposition of abnormal substances in the heart tissue, causing diastolic, less often systolic, dysfunction of the ventricle(s). Their classification still does not exist.
Elena V Reznik +3 more
doaj +3 more sources
Infiltrative Disease Presenting with an Inflamed Heart
Journal of Cardiovascular Magnetic ResonancePaula Poveda Velazquez +5 more
doaj +2 more sources
A giant mystery in giant cell myocarditis: navigating diagnosis, immunosuppression, and mechanical circulatory support. [PDF]
, 2020 Giant cell myocarditis is a rare but often devastating diagnosis. Advances in cardiac imaging and mechanical circulatory support have led to earlier and more frequent diagnoses and successful management. This disease state has wide variation in acuity of
Dunn, Steven P +3 more
core +1 more source
F1000Research, 2023 Cardiac amyloidosis (CA), a significant condition resulting in infiltrative cardiomyopathy and heart failure with preserved ejection fraction (HFpEF), is caused by extracellular deposition of amyloid fibrils in the heart.
Labdhi Sanghvi +9 more
doaj +1 more source
An overview of the current genetic and phenotypical selection strategies to reduce the prevalence of feline hypertrophic cardiomyopathy = Een overzicht van de huidige genetische en fenotypische selectiestrategieën tegen hypertrofe cardiomyopathie bij de kat [PDF]
, 2020 Hypertrophic cardiomyopathy (HCM) is a common and potentially lethal heart disease in cats. To reduce its prevalence, breeding cats are frequently screened on the basis of their phenotype or genotype.
Broeckx, Bart +3 more
core +1 more source
Heart Fat Infiltration In Subjects With and Without Coronary Artery Disease [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2015 Fat may accumulate around the heart in epicardial adipose tissue or inside the heart as lipid droplets (LDs).To compare myocardial steatosis between subjects with and without coronary artery disease (CAD and non-CAD) and to identify which cells contain LDs.Body mass index, waist circumference, glucose, insulin, homeostasis model assessment index ...
MAZZALI, Gloria +13 more
openaire +5 more sources
Features of Diagnostics and Course of Hypertrophic Cardiomyopathy in Real Clinical Practice
Архивъ внутренней медицины, 2023 Introduction and purpose. Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular (LV) wall thickening not associated with increased afterload (hypertension and aortic stenosis), is usually caused by mutations in sarcomeric protein genes ...
E. V. Reznik +7 more
doaj +1 more source